Tuttiquotidiani e completamente gratuito. Ogni giorno aggreghiamo notizie da oltre 100 testate e generiamo sintesi AI originali per te. Aiutaci a mantenere il servizio attivo con una piccola donazione, oppure diventa TQ Pro da solo 1€/mese.

Fai una donazione TQ Pro - 1€/mese
  1. Home

This pharmaceutical stock is cheap relative to peers. UBS thinks it's due for a bounce

  • Posted on April 22, 2026
  • By CNBC
  • 0 Views
  • 1 min read
This pharmaceutical stock is cheap relative to peers. UBS thinks it's due for a bounce
This pharmaceutical stock is cheap relative to peers. UBS thinks it's due for a bounce

The investment bank upgraded the pharmaceutical name to buy from neutral.
continue reading...

Author
CNBC

You May Also Like